Search research articles
Contact Us
Filters
Showing results (171-180 of 204) with videos related to
Page
of 21
Sort By:
Leukemia
|
March 13, 2001
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing
J E Sarriera, M Albitar, Z Estrov, et al.
Seminars in Oncology
|
June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital
M J Keating, E Estey, W Plunkett, et al.
Leukemia
|
October 27, 1997
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
H M Kantarjian, S M O'Brien, M Keating, et al.
Blood
|
February 1, 1992
The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction
K S Chang, J F Lu, G Wang, et al.
Cancer
|
August 15, 1990
High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission
J A Spinolo, K A Dicke, L J Horwitz, et al.
Blood
|
September 9, 2000
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
A Aguayo, H Kantarjian, T Manshouri, et al.
Cancer Research
|
September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia
S M Kornblau, H J Xu, A del Giglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature
B Quesnel, H Kantarjian, J P Bjergaard, et al.
Leukemia
|
September 11, 2014
Value of routine 'day 14' marrow exam in newly diagnosed AML
T Yezefski, H Xie, R Walter, et al.
Blood
|
August 1, 1992
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia
D F Claxton, C L Reading, L Nagarajan, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 204) with videos related to
Sort By:
Page
of 21
Leukemia
|
March 13, 2001
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing
J E Sarriera, M Albitar, Z Estrov, et al.
Seminars in Oncology
|
June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital
M J Keating, E Estey, W Plunkett, et al.
Leukemia
|
October 27, 1997
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
H M Kantarjian, S M O'Brien, M Keating, et al.
Blood
|
February 1, 1992
The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction
K S Chang, J F Lu, G Wang, et al.
Cancer
|
August 15, 1990
High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission
J A Spinolo, K A Dicke, L J Horwitz, et al.
Blood
|
September 9, 2000
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
A Aguayo, H Kantarjian, T Manshouri, et al.
Cancer Research
|
September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia
S M Kornblau, H J Xu, A del Giglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature
B Quesnel, H Kantarjian, J P Bjergaard, et al.
Leukemia
|
September 11, 2014
Value of routine 'day 14' marrow exam in newly diagnosed AML
T Yezefski, H Xie, R Walter, et al.
Blood
|
August 1, 1992
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia
D F Claxton, C L Reading, L Nagarajan, et al.
Page
of 21